Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 13;15(9):e45150.
doi: 10.7759/cureus.45150. eCollection 2023 Sep.

Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review

Affiliations
Review

Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review

Mehvish Sohail et al. Cureus. .

Abstract

Stent thrombosis (ST) is a rare but catastrophic event to happen to a stented coronary artery. The incidence of ST has greatly been reduced after the advent of modern drug-eluting stent (DES) implants, which have become the most preferred treatment option in the stenting category for coronary artery disease (CAD). Although the risk reduction by newer category implant provides substantial benefits, the possibility of thrombosis still exists mostly during the early stage of DES implantation. The development of ST after percutaneous coronary intervention (PCI) can be predicted by multiple factors, but advancements in early diagnostic techniques and modified stent types have greatly reduced the occurrence of this complication. Mortality, which is one of the complications of ST, is primarily influenced by patient-related factors such as incomplete treatment duration of dual antiplatelet therapy (DAPT). The duration of DAPT after DES implantation in patients with acute coronary syndrome (ACS) is determined based on individual characteristics, mainly considered in view of bleeding or ischemia risk. Risk evaluation systems like DAPT/precise-DAPT scores help tailor and personalize the duration of DAPT for each individual patient. This systematic review contains pertinent articles extracted from the PubMed database. We retrieved articles from various study categories, encompassing publications from the period spanning 2014 to 2022. Our analysis highlighted results from studies investigating different aspects contributing to ST development. The most favorable prevention option was the use of customized DAPT intervention based on patient-specific predictable factors. Several complications associated with ST were identified, including recurrent ST, major adverse cardiovascular events (MACE) encompassing all-cause mortality (including cardiac and non-cardiac mortality), cerebrovascular accidents (CVA) or transient ischemic attacks (TIA), hospitalization due to heart failure, and myocardial infarction requiring revascularization. Mortality was also observed as a significant outcome. The umbrella term of ST includes multiple causative factors. Although DES has improved patient survival rates vastly with its usage, careful risk factor assessment and required follow-up, in each individual being stented, further guarantee a more promising reduction in late adverse outcomes.

Keywords: coronary artery disease (cad); drug eluting stents (des); dual-antiplatelet therapy (dapt); post pci; stent thrombos.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) flowchart

Similar articles

References

    1. Risk factors and long term clinical outcomes of second generation drug-eluting stent thrombosis, Insights From the REAL-ST Registry. Kuramitsu S, Ohya M, Shinozaki T, et al. Circ Cardiovasc Interv. 2019;12:0. - PubMed
    1. Incidence, predictors, and outcomes of acute and sub-acute stent thrombosis after emergency percutaneous coronary revascularization with drug-eluting stents: a prospective observational study. Kumar R, Ammar A, Saghir T, et al. Glob Heart. 2022;17:24. - PMC - PubMed
    1. Coronary stent thrombosis-predictor and prevention. Ullrich H, Münzel T, Gori T. Dtsch Arztebl Int. 2020;117:320–326. - PMC - PubMed
    1. Stent thrombosis: a clinical perspective. Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD. JACC Cardiovasc Interv. 2014;7:1081–1092. - PubMed
    1. Drug-eluting stent thrombosis: current and future perspectives. Kuramitsu S, Sonoda S, Ando K, et al. Cardiovasc Interv Ther. 2021;36:158–168. - PubMed

LinkOut - more resources